tradingkey.logo

J&J resumes US rollout of Varipulse heart device after investigation

ReutersFeb 15, 2025 4:57 AM

- Johnson & Johnson JNJ.N said on Friday it has resumed the limited market release of its Varipulse heart device in the United States after an investigation found the devices operate as intended.

In January, the company had paused the heart device, a pulsed field ablation system, citing an abundance of caution as it investigated four reported stroke events.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI